1. Home
  2. EOLS vs LAC Comparison

EOLS vs LAC Comparison

Compare EOLS & LAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • LAC
  • Stock Information
  • Founded
  • EOLS 2012
  • LAC 2023
  • Country
  • EOLS United States
  • LAC Canada
  • Employees
  • EOLS N/A
  • LAC N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • LAC Metal Mining
  • Sector
  • EOLS Health Care
  • LAC Basic Materials
  • Exchange
  • EOLS Nasdaq
  • LAC Nasdaq
  • Market Cap
  • EOLS 787.7M
  • LAC 709.7M
  • IPO Year
  • EOLS 2018
  • LAC N/A
  • Fundamental
  • Price
  • EOLS $11.35
  • LAC $3.10
  • Analyst Decision
  • EOLS Strong Buy
  • LAC Hold
  • Analyst Count
  • EOLS 6
  • LAC 8
  • Target Price
  • EOLS $22.60
  • LAC $5.06
  • AVG Volume (30 Days)
  • EOLS 504.4K
  • LAC 5.0M
  • Earning Date
  • EOLS 11-06-2024
  • LAC 11-07-2024
  • Dividend Yield
  • EOLS N/A
  • LAC N/A
  • EPS Growth
  • EOLS N/A
  • LAC N/A
  • EPS
  • EOLS N/A
  • LAC N/A
  • Revenue
  • EOLS $248,326,000.00
  • LAC N/A
  • Revenue This Year
  • EOLS $33.43
  • LAC N/A
  • Revenue Next Year
  • EOLS $32.44
  • LAC N/A
  • P/E Ratio
  • EOLS N/A
  • LAC N/A
  • Revenue Growth
  • EOLS 34.42
  • LAC N/A
  • 52 Week Low
  • EOLS $9.65
  • LAC $2.02
  • 52 Week High
  • EOLS $17.82
  • LAC $7.71
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 35.09
  • LAC 33.77
  • Support Level
  • EOLS $11.34
  • LAC $3.16
  • Resistance Level
  • EOLS $11.83
  • LAC $3.76
  • Average True Range (ATR)
  • EOLS 0.46
  • LAC 0.18
  • MACD
  • EOLS -0.00
  • LAC -0.08
  • Stochastic Oscillator
  • EOLS 14.41
  • LAC 0.00

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About LAC Lithium Americas Corp.

Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, that is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass recently began construction and is expected to begin production in the mid- to late 2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.

Share on Social Networks: